Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer

被引:0
|
作者
Vanasek, J. [1 ,7 ,8 ]
Odrazka, K. [1 ,8 ]
Dusek, L. [2 ,3 ]
Jarkovsky, J. [2 ,3 ]
Michalek, R. [6 ]
Chrobok, V. [4 ,5 ]
Dolezel, M. [1 ]
Kolarova, I. [1 ,7 ,8 ]
机构
[1] Oncol Ctr Multiscan, Pardubice, Czech Republic
[2] Masaryk Univ, Fac Med, Inst Biostat & Analyses, Brno, Czech Republic
[3] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic
[4] Charles Univ Prague, Univ Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Hradec Kralove, Czech Republic
[5] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic
[6] Reg Hosp, Otorhinolaryngol & Head & Neck Surg Clin, Pardubice, Czech Republic
[7] Pardubice Univ, Fac Hlth Studies, Pardubice, Czech Republic
[8] Fac Mil Hlth Sci, Dept Radiobiol, Hradec Kralove, Czech Republic
来源
JOURNAL OF BUON | 2013年 / 18卷 / 04期
关键词
head and neck cancer; IMRT; radiotherapy; relapse; survival; RADIATION-THERAPY; IMRT; PATTERNS; CARCINOMA; FAILURE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Studies using intensity-modulated radiation therapy (IMRT) in the treatment of head and neck tumors have shown to decrease acute and late radiation toxicity. However, the high conformity of this technique can increase the risk of recurrence due to geographic miss. The aim of this study was to analyze whether the results of IMRT met the theoretical expectations concerning treatment efficacy. Methods: From a total of 185 patients (152 males and 33 females, mean age 58+/-10.36 years) 176 were evaluable and were studied. Eighty-nine (48.1%) patients had surgical treatment and 50 of them were scheduled for concomitant cisplatin chemotherapy. Irradiation was performed using IMRT, a sliding window with 9 fields in a Varian 2100 C/D linear accelerator, X-ray beam, 6 MeV. The prescribed dose in the planning treatment volume (PTV1), i.e., the area of the primary tumor and nodal area, was 66 Gy/2.2 Gy-70 Gy/2.12 Gy. In the PTV2 (the area at high risk) the dose was 60Gy/2 Gy-59.4 Gy/ 1.8 Gy, and in the PTV 3 (the area treated with prophylactic irradiation) the prescribed dose was 54 Gy/1.8 Gy-50.4 Gy/1.53 Gy. Results: The 3-year overall survival (OS) and relapse-free survival (RFS) of IMRT-treated patients, most of whom were in stages III and IV (158 out of 177), were 50 and 57%, respectively. Using postoperative radiotherapy/chemoradiotherapy 3-year locoregioncal control was achieved in 75% of the cases as compared with 35% in non-operated patients. Conclusions: The worst outcomes were found in oral cavity and hypopharyngeal tumors, and the best in laryngeal and oropharyngeal tumors. Better results were found in surgically treated patients, and in lower disease stages. Despite the high conformity of dose distribution and efforts to spare healthy tissues, most cases of locoregional relapse occurred in areas receiving the full radiation dose. If dividing relapses into cases of persistence and local recurrence, the former predominated.
引用
收藏
页码:970 / 976
页数:7
相关论文
共 50 条
  • [41] Intensity modulated radiotherapy in the treatment of head and neck unknown primary cancer
    Lu, H.
    Yao, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S419 - S419
  • [42] Intensity-modulated Radiotherapy for the Treatment of Breast Cancer
    Coles, C. E.
    Donovan, E.
    Haviland, J.
    Yarnold, J.
    [J]. CLINICAL ONCOLOGY, 2013, 25 (03) : 215 - 215
  • [43] Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer
    Schwartz, Matthew
    Vuong, Te
    Ballivy, Olivier
    Parker, William
    Patrocinio, Horacio
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (04) : 549 - 555
  • [44] Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer
    Chen, A. M.
    Hall, W. H.
    Li, B-Q
    Guiou, M.
    Wright, C.
    Mathai, M.
    Dublin, A.
    Purdy, J. A.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (997): : 58 - 63
  • [45] Patterns of failure of head and neck patients treated with intensity-modulated radiotherapy
    Scrimger, R
    Parliament, M
    Thompson, H
    Field, C
    Mackey, J
    Jha, N
    Hanson, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S12 - S12
  • [46] Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice
    Bednarek, C.
    Nguyen, T. V. F.
    Puyraveau, M.
    Bonnet, E.
    Lescut, N.
    Azelie, C.
    Miny, J.
    Mauvais, O.
    Maurina, T.
    Tochet, F.
    Bosset, J. -F.
    Thariat, J.
    Sun, X. S.
    [J]. CANCER RADIOTHERAPIE, 2017, 21 (01): : 21 - 27
  • [47] Quality of Life, Anxiety, and Depression in the Head-and-Neck Cancer Patients, Undergoing Intensity-Modulated Radiotherapy Treatment
    Nikoloudi, Maria
    Lymvaios, Ioannis
    Zygogianni, Anna
    Parpa, Efi
    Strikou, Dimitra-Aspasia
    Tsilika, Eleni
    Kouloulias, Vassilios
    Mystakidou, Kyriaki
    [J]. INDIAN JOURNAL OF PALLIATIVE CARE, 2020, 26 (01) : 54 - 59
  • [48] Is Daily Image-guided Radiotherapy (IGRT) Really Necessary in the Treatment of Head and Neck Cancer with Intensity-modulated Radiotherapy (IMRT)?
    Marsano, J. G.
    Won, S.
    Li, B.
    Sreeraman, R.
    Michaud, A.
    Perks, J.
    Purdy, J. A.
    Chen, A. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S638 - S639
  • [49] Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region
    Verellen, D
    Linthout, N
    VandenBerge, D
    Bel, A
    Storme, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01): : 99 - 114
  • [50] Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory
    Duprez, Frederic
    Madani, Indira
    Bonte, Katrien
    Boterberg, Tom
    Vakaet, Luc
    Derie, Cristina
    De Gersem, Werner
    De Neve, Wilfried
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 563 - 569